Pharmacokinetics of eslicarbazepine acetate in patients with renal impairment.

被引：0
|
作者：
Almeida, Luis [1 ]
Potgieter, J. Henk [1 ]
Maia, Joana [1 ]
Soares-da-Silva, P. [1 ]
机构：
[1] Univ Free State, Farmovs Parexel, Bloemfontein, South Africa
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2007年 / 47卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
47
引用
收藏
页码：1193 / 1193
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics of eslicarbazepine acetate in patients with moderate liver impairment.
    Maia, Joana
    Potgieter, J. Henk
    Almeida, Luis
    Soares-da-Silva, P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1192 - 1192
  • [2] Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate
    Maia, Joana
    Almeida, L.
    Potgieter, J. H.
    Soares-da-Silva, P.
    EPILEPSIA, 2007, 48 : 337 - 337
  • [3] Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate
    Maia, J.
    Almeida, L.
    Falcao, A.
    Soares, E.
    Mota, F.
    Potgieter, M. A.
    Potgieter, J. H.
    Soares-da-Silva, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (03) : 119 - 130
  • [4] Pharmacokinetics of frovatriptan in patients with renal impairment.
    Cohen, AF
    van der Post, J
    Sacks, S
    Marsh, J
    Buchan, P
    CEPHALALGIA, 1999, 19 (04) : 365 - 365
  • [5] Pharmacokinetics of pioglitazone in patients with renal impairment.
    Edwards, G
    Eckland, DJA
    DIABETOLOGIA, 1999, 42 : A230 - A230
  • [6] Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment
    Luis Almeida
    J. Hendrick Potgieter
    Joana Maia
    M. Alida Potgieter
    Fernando Mota
    P. Soares-da-Silva
    European Journal of Clinical Pharmacology, 2008, 64 : 267 - 273
  • [7] Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment
    Almeida, Luis
    Potgieter, J. Hendrick
    Maia, Joana
    Potgieter, M. Alida
    Mota, Fernando
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (03) : 267 - 273
  • [8] EFFECT OF FIMASARTAN ON PHARMACOKINETICS IN PATIENTS WITH RENAL IMPAIRMENT.
    Kim, S.
    Shin, D.
    Kim, Y. S.
    Cho, S. H.
    Jang, I. J.
    Lee, H.
    Yu, K. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S72 - S72
  • [9] The Pharmacokinetics of Voclosporin (VCS) in Renal Impairment.
    Freitag, D.
    Huizinga, R.
    Mayo, P.
    Ling, S.
    Foster, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 335 - 335
  • [10] Effect of moderate liver impairment on the eslicarbazepine acetate pharmacokinetics
    Almeida, Luis
    Maia, J.
    Potgieter, J. H.
    Soares-da-Silva, P.
    EPILEPSIA, 2007, 48 : 339 - 339
12345